Phenylalanine
- Generic Name
- Phenylalanine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11NO2
- CAS Number
- 63-91-2
- Unique Ingredient Identifier
- 47E5O17Y3R
- Background
Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, dopamine, noradrenalin (norepinephrine), and thyroxine.
- Indication
L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
- Associated Conditions
- -
- Associated Therapies
- Amino acid supplementation
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical trial shows PKU GOLIKE reduces harmful phenylalanine and increases beneficial tyrosine levels during fasting, improving metabolic control in PKU patients.
Gut microbiome, blood glucose clinical trials most requested among Japan FFC firms
Japan's Foods with Function Claims (FFC) system allows specific health claims backed by evidence, with gut microbiome and blood glucose management studies being most common. Only 10% of FFC companies conduct clinical trials, mostly large firms. Healthy ageing and visceral fat reduction trials are also prevalent. Small and medium-sized companies typically rely on systematic reviews due to resource constraints, but standards for these reviews have recently increased.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath